VINDESINE THERAPY IN MELPHALAN-RESISTANT MULTIPLE-MYELOMA

被引：24

作者：

HOUWEN, B

OCKHUIZEN, T

MARRINK, J

NIEWEG, HO

机构：

[1] STATE UNIV GRONINGEN,DIV HAEMATOL,GRONINGEN,NETHERLANDS

[2] STATE UNIV GRONINGEN,DEPT INTERNAL MED,IMMUNOCHEM LAB,GRONINGEN,NETHERLANDS

来源：

EUROPEAN JOURNAL OF CANCER | 1981年 / 17卷 / 02期

关键词：

D O I：

10.1016/0014-2964(81)90040-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：227 / 232

页数：6

共 21 条

[1]

ALEXANIAN R, 1972, CANCER-AM CANCER SOC, V30, P382, DOI 10.1002/1097-0142(197208)30:2<382::AID-CNCR2820300213>3.0.CO

[2]

2-C

[3]

ALEXANIAN R, 1977, CANCER, V40, P2765, DOI 10.1002/1097-0142(197712)40:6<2765::AID-CNCR2820400602>3.0.CO

[4]

2-X

[5]

ALEXANIAN R, 1977, RECENT ADV CANCER TR, P19

[6] PHASE-II TRIAL WITH VINDESINE FOR REGRESSION INDUCTION IN PATIENTS WITH LEUKEMIAS AND HEMATOSARCOMAS [J].

BAYSSAS, M ;

GOUVEIA, J ;

RIBAUD, P ;

MUSSET, M ;

VASSAL, FD ;

PICO, JL ;

LUCA, LD ;

MISSET, JL ;

MACHOVER, D ;

BELPOMME, D ;

SCHWARZENBERG, L ;

JASMIN, C ;

HAYAT, M ;

MATHE, G .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1979, 2 (04) :247-255

[7]

BERGSAGEL DE, 1972, CAN MED ASSOC J, V107, P851

[8]

DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO

[9]

2-U

[10]

GRALLA RJ, 1979, CANCER TREAT REP, V63, P1343

← 1 2 3 →